Laurantis Pharma
Turku
About Laurantis Pharma
Laurantis Pharma Oy is a specialty pharmaceutical development company with a broad, clinical-stage portfolio in three therapeutic areas: dermatology, ophthalmology, and oncology. Using two proprietary technologies, Laurantis is developing first-in-class products for commercially and medically significant niche indications in these areas. Laurantis was formed in December 2010 through a merger of the Finnish drug development companies Oy Lx Therapies Ltd and BioCis Pharma Oy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.1M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2012)
- Website: laurantis.com
- Phone: +358 2478 8378
Industries & Categories
Biotechnology, Oncology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/laurantis-pharma-2639960 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.